Caris Assure Blood Based Profiling | Molecular Minute Podcast

Caris President Dr. David Spetzler and Caris Precision Oncology Alliance™ Chairman Dr. Chadi Nabhan sat down to discuss our minimally-invasive liquid biopsy assay, Caris Assure™. Learn more about the powerful assay and how it will impact the future of precision medicine.
Get additional information: www.carislifesciences.com/pro...

[@-myal-8691]

Fascinating.

[@Mirtunjaya78]

It is a great podcast but I believe the next challenge would be to detect and characterize the liquid biopsy profile of patients to specific cancer or cancer type especially if cancer is early stage and benign than more aggressive phenotype and shedding its signature in blood. I believe Caris Assure would be a game changer in tracking and treating hematological malignancy and also its response to immunotherapy

[@-myal-8691]

How can cancer cells learn to resist chemotherapies?